NWXUX
Price
$12.37
Change
-$0.01 (-0.08%)
Updated
Jun 2 closing price
Net Assets
299.95M
PICOX
Price
$46.28
Change
-$0.24 (-0.52%)
Updated
Jun 2 closing price
Net Assets
342.72M
Interact to see
Advertisement

NWXUX vs PICOX

Header iconNWXUX vs PICOX Comparison
Open Charts NWXUX vs PICOXBanner chart's image
NWXUX vs PICOX Comparison Chart in %
View a ticker or compare two or three
VS
NWXUX vs. PICOX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWXUX is a StrongBuy and PICOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PICOX has more cash in the bank: 343M vs. NWXUX (300M). PICOX pays higher dividends than NWXUX: PICOX (5.98) vs NWXUX (4.35). NWXUX was incepted earlier than PICOX: NWXUX (9 years) vs PICOX (8 years). PICOX (1.15) and NWXUX (1.12) have similar cost to investors . NWXUX is a more actively managed with annual turnover of: 132.52 vs. PICOX (30.00). PICOX has a lower initial minimum investment than NWXUX: PICOX (0) vs NWXUX (1000000). NWXUX annual gain was more profitable for investors over the last year : 20.63 vs. PICOX (4.45). NWXUX return over 5 years is better than : 12.70 vs. PICOX (11.90).
NWXUXPICOXNWXUX / PICOX
Total Expense Ratio0.891.0585%
Annual Report Gross Expense Ratio1.121.1597%
Fund Existence9 years8 years-
Gain YTD12.2393.217380%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets300M343M87%
Annual Yield % from dividends4.355.9873%
Returns for 1 year20.634.45464%
Returns for 3 years57.8240.32143%
Returns for 5 years12.7011.90107%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNM50.481.40
+2.85%
Core & Main
STEL37.370.59
+1.60%
Stellar Bancorp
CRACU10.22N/A
N/A
Crown Reserve Acquisition Corp. I
DWTX1.68-0.02
-1.18%
Dogwood Therapeutics Inc
IPSC2.18-0.18
-7.63%
Century Therapeutics